Vaping Related DisorderNCT07499557
Radiology and BAL in Vaping Associated Lung Injury
An observational study of Vaping Related Disorder, run by Alexandria University at 1 site in Egypt.
Trial summary
Radiology and BAL in Vaping associated lung disease Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Vaping Related Disorder
- How many people
- 60 participants
- Where
- 1 siteEgypt
- Study dates
- 25 Jan 2025to 25 Mar 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: persons who had history of vaping alot of years with chest symptoms
Who may be able to join
- 1. Age ≥ 18 years
- 2. Acute respiratory symptoms (dyspnea, cough, chest discomfort, or hypoxemia.
- 3. Documented use of E-cigarettes or vaping products within 90 days.
- 4. Availability of CT chest imaging and chest ultrasound at presentation.
- 5. BAL performed during the initial diagnostic work-up.
Who cannot join
- 1-Confirmed alternative diagnoses such as cardiac failure, infectious pneumonia, pulmonary embolism, autoimmune disease, or drug-induced lung injury.
- 2-Refusal of the study
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Role of Chest CT, Ultrasound, and Bronchoalveolar Lavage in Vaping-Associated Lung Injury
Radiology and BAL in Vaping associated lung disease
Read the detailed description
vaping leads to alot of problems to the respiratrory system and to dertermine the effect accurately,CT and ultrasound chest together with BAL in fit patients will be done
- Conditions
- Vaping Related Disorder
- Keywords
- bronchoalveolar lavage, Vaping, Ultrasound
- Medical subject headings
- Vaping
What is being measured
The primary outcome is the main question the study is designed to answer.
Diagnostic yield of radiology plus bronchoscopy in vaping associated lung diseases
icu admission rate ,length of hospital stay ,mortality rate
Measured: one year
Secondary outcomes (1)
mortality
death versus deterioration of the patients
Measured: one year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Mar 2026
- Study start25 Jan 2025
- Primary completion11 Jan 2026
- Study completion25 Mar 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Vaping Related DisorderStudies of the same condition, open and under way.
- More trials run by Alexandria UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Alexandria University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mohamed Sabry, Alexandria University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07499557
- Sponsor's protocol ID
- Univ fac med
- Status last verified
- Mar 2026
- First submitted
- 24 Mar 2026
- Last updated
- 30 Mar 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Role of Chest CT, Ultrasound, and Bronchoalveolar Lavage in Vaping-Associated Lung Injury
- ClinicalTrials.gov ID
- NCT07499557
- Acronym / sponsor ID
- Univ fac med
- Conditions
- Vaping Related Disorder
- Keywords
- bronchoalveolar lavage, Vaping, Ultrasound
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Alexandria UniversityUniversity, hospital or other
- Study start
- 25 Jan 2025 (actual)
- Primary completion
- 11 Jan 2026 (actual)
- Study completion
- 25 Mar 2026 (actual)
- First posted
- 30 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Radiology and BAL in Vaping associated lung disease
Detailed description
vaping leads to alot of problems to the respiratrory system and to dertermine the effect accurately,CT and ultrasound chest together with BAL in fit patients will be done
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- persons who had history of vaping alot of years with chest symptoms
Key inclusion criteria (5 listed)
- 1. Age ≥ 18 years
- 2. Acute respiratory symptoms (dyspnea, cough, chest discomfort, or hypoxemia.
- 3. Documented use of E-cigarettes or vaping products within 90 days.
- 4. Availability of CT chest imaging and chest ultrasound at presentation.
- 5. BAL performed during the initial diagnostic work-up.
Key exclusion criteria (2 listed)
- 1-Confirmed alternative diagnoses such as cardiac failure, infectious pneumonia, pulmonary embolism, autoimmune disease, or drug-induced lung injury.
- 2-Refusal of the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Diagnostic yield of radiology plus bronchoscopy in vaping associated lung diseases
Time frame: one year
icu admission rate ,length of hospital stay ,mortality rate
1 secondary outcome
mortality
Time frame: one year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Mar 2026.
- E-cigarette vaping associated acute lung injury (EVALI): state of science and future research needsLink provided by the sponsor.
Related trials for Vaping Related Disorder
Not yet recruitingEarly Phase 1
Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis
Cannabis Use, Tobacco
Recruiting
Young Adult Tobacco/Nicotine and Cannabis Co-use
Tobacco Use Disorder, Nicotine Dependence
Recruiting
Social Media Support Groups for Adolescent Vaping Cessation
Vaping, Vaping Cessation
RecruitingObservational study
§SMOKE Nicotine and Tobacco Youth Cohort
Tobacco Use Behavior, Nicotine Dependence Tobacco Product
Recruiting
Developing an E-Cigarette Cessation Intervention for Hispanic/Latina(o) Youth in Florida: The BReATHE Study
Vaping Teens, Vaping Behaviors
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Vaping Related Disorder, run by Alexandria University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Diagnostic yield of radiology plus bronchoscopy in vaping associated lung diseases (time frame: one year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Mar 2026.